CMN Weekly (1 October 2021)

Some of the best links we picked up around the internet

By: Gorm Palmgren - Oct. 1, 2021

Top picks

Research

Industry

COVID-19

Reviews

Huh, heh, wow

  • The world's first CRISPR gene-edited food has recently gone on sale in Japan in the form of a tomato packed with a likely increase in nutritional content. CRISPR has enabled the tomato variety, Sicilian Rouge High GABA, to reduce the breakdown of GABA, so the tomatoes have around five times as much GABA in them. GABA is the chief inhibitory neurotransmitter in the human central nervous system, and the tomatoes are expected to reduce blood pressure in consumers.

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

CLINICAL TRIALS
Acute Myeloid Leukemia, AML, (NCT05066165)
Sponsors:
Intellia Therapeutics
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
CAR T for CD19+ hematological cancers, (NCT05037669)
Sponsors:
University of Pennsylvania
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine